Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing DPYD Genotyping Method for Personalized Fluoropyrimidines Therapy. | J Appl Lab Med | 2024 | 38084968 | PubTator, text mining | PubMed |
| Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancer. | Drug Discov Today | 2024 | 38070703 | PubTator, text mining | PubMed |
| Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles. | Clin Pharmacol Ther | 2024 | 38060335 | PubTator, text mining | PubMed |
| A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens. | Clin Pharmacol Ther | 2024 | 37957132 | PubTator, text mining | PubMed |
| jMorp: Japanese Multi-Omics Reference Panel update report 2023. | Nucleic Acids Res | 2024 | 37930845 | PubTator, text mining | PubMed |
| DPYD genotyping and 5-fluoropyrimidine toxicity: An overview of systematic reviews protocol. | Farm Hosp | 2024 | 37758638 | PubTator, text mining | PubMed |
| DPD deficiency in an Irish oncology centre: Prevalence and clinical implications. | J Oncol Pharm Pract | 2024 | 37559385 | PubTator, text mining | PubMed |
| Reconciling the biomedical data commons and the GDPR: three lessons from the EUCAN ELSI collaboratory. | Eur J Hum Genet | 2024 | 37322132 | PubTator, text mining | PubMed |
| Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists. | J Oncol Pharm Pract | 2024 | 37021580 | PubTator, text mining | PubMed |
| Implementation of pharmacogenomics: Where are we now? | Br J Clin Pharmacol | 2024 | 36366858 | PubTator, text mining | PubMed |
| Genomic landscape in Saudi patients with hepatocellular carcinoma using whole-genome sequencing: a pilot study. | Front Gastroenterol (Lausanne) | 2023 | 41821813 | PubTator, text mining | PubMed |
| Customizing the electronic health record for delivery of pharmacogenetics. | Genet Med Open | 2023 | 39669236 | PubTator, text mining | PubMed |
| Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. | Front Pharmacol | 2023 | 38269272 | PubTator, text mining | PubMed |
| Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges. | Front Pharmacol | 2023 | 38264526 | PubTator, text mining | PubMed |
| Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials. | Front Pharmacol | 2023 | 38259276 | PubTator, text mining | PubMed |
| Esophageal Cancer with Early Onset in a Patient with Cri du Chat Syndrome. | Diseases | 2023 | 38248360 | PubTator, text mining | PubMed |
| Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer. | Int J Mol Sci | 2023 | 38203276 | PubTator, text mining | PubMed |
| JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer. | Cancers (Basel) | 2023 | 38201452 | PubTator, text mining | PubMed |
| Capecitabine for Salvage Treatment of Patients With Heavily Pretreated Human Papillomavirus-Associated Oropharynx Cancer With Distant Metastases. | J Adv Pract Oncol | 2023 | 38196671 | PubTator, text mining | PubMed |
| 5-Fluorouracil Neurotoxicity in a Patient With Normal Dihydropyrimidine Dehydrogenase Activity. | Cureus | 2023 | 38174188 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=17